NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

NCT03734809 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

NPC

Interventions

DRUG: Pembrolizumab

Sponsor

Chinese University of Hong Kong